Vaccination with recombinant HBsAg-HBIG complex in healthy adults

Vaccine

Volumn 23, Issue 20, 2005, Pages 2658-2664

  Xu, Dao Zhen ^a   Huang, Ke Lin ^a   Zhao, Kai ^b   Xu, Li Feng ^b   Shi, Nan ^b   Yuan, Zheng Hong ^c   Wen, Yu Mei ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Institute of Biological Products   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Anti HBs; HBsAg HBIG; Vaccine

Indexed keywords

ALUMINUM POTASSIUM SULFATE; GAMMA INTERFERON; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; RECOMBINANT ANTIGEN; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; ADULTHOOD; ARTICLE; BLOOD CHEMISTRY; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FEMALE; HEALTH STATUS; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INJECTION SITE REACTION; KIDNEY FUNCTION; LABORATORY TEST; LIVER FUNCTION; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RECIPIENT; SIDE EFFECT; SKIN DEFECT; SKIN NODULE; VACCINATION; VOLUNTEER; YEAST;

EID: 15244348547     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.10.040     Document Type: Article

References (19)

1. World Health Organization. State of the world's vaccines and immunization. Global Programme for Vaccines and Immunization. WHO/GPV/96.04, 1996.
2. A.S.F. Lok, H.T. Chung, V.W.S. Liu, and O.c.k. Ma Long-term follow-up of chronic hepatitis B treated with interferon-alpha Gastroenterology 105 16 1993 1833 1838
3. C.L. Lai, R.N. Chien, N.W. Leung, T.T. Chang, R. Guan, D.I. Tai Asia Hepatitis Lamivudine Study Group A one-year trial of lamivudine for chronic hepatitis B N Engl J Med 339 2 1998 61 68
4. E. Villa, V. Boarino, Grottola, R. Gelmini, and N.G. Lama Predominance of pre-S1 mutated hepatitis B virus in a patient following treatment with adefovir dipivoxial Liver Transpl 9 2 2002 188 190
5. S. Pol, F. Driss, M.L. Michel, B. Nalpas, P. Berhelot, and C. Brechot Specific vaccine therapy in chronic hepatitis B infection Lancet 344 8918 1994 342
6. M. Mancini, M. Hadchouel, P. Tiollais, C. Poircel, and M.L. Michel Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice "a possible way of circumventing nonresponse" to HBsAg J Med Virol 39 1 1993 67 74
7. M. Macini, M. Hadchouel, H.K. Davis, R.G. whalne, P. Tiollais, and M.L. Michel DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state Proc Natl Acad Sci USA 93 22 1996 12496 12501
8. A. Viiello, G. Ishioka, H.M. Grey, R. Rose, P. Farness, and R. LaFond Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection J Clin Invest 95 1 1999 341 349
9. R. Schirmbeck, X. Zheng, M. Roggendorf, M. Geissler, F.V. Chisari, and J. Reimann Targeting marine immune responses to selected T cell or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen J Immunol 166 2 2001 1405 1413
10. Y.M. Went, S.D. Xiong, and W. Zhang Solid matrix-antibody-antigen complex can clear viremia and antigenemia in persistent duck hepatitis B virus infection J Gen Virol 75 pt. 2 1994 335 339
11. Y.M. Wen, S.Q. Guo, and S.D. Xiong Therapeutic vaccine studies on viral hepatitis B in animal models S. Jameel E.K. Wagner Current Developments in animal Virology 1996 Oxford & IBH Publishing Co. New Delhi p. 375-9
12. Y.M. Wen, X.H. Wu, D.C. Hu, Q.P. Zhang, and S.Q. Guo Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy Lancet 345 8964 1995 1575 1576 67-74
13. G. Carayanniotis, and B.H. Barber Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC Nature 327 6117 1987 59 61
14. R.E. Randall, and D.F. Young Humoral and cytotoxic T cell immune responses to internal and external structural proteins of simian virus 5 induced by immunization with solid matrix-antibody-antigen complexes J Gen Virol 69 10 1988 2505 2516
15. E. Celis, V.R. Zurawaki, and T.W. Chang Regulation of T cell function by antibodies: enhancement of the response of human T cell clones to hepatitis surface antigen by antigen-specific monoclonal antibodies Proc Natl Acad Sci USA 81 21 1984 6846 6850
16. Y.M. Wen, D. Qu, and S.H. Zhou Antigen-antibody complex as therapeutic vaccine for viral hepatitis B Int Rev Immunol 18 3 1999 251 258
17. B. Martinez-Kinader, G.B. Lipford, H. Wagner, and K. Heeg Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway Immunology 86 2 1995 287 295
18. B.J. Zheng, M.H. Ng, L.F. He, X. Yao, K.W. Chan, and K.Y. Yuen Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice Vaccine 19 30 2001 4219 4225
19. C.G. Cochrane, and D. Koffler Immune complex disease in experimental animals and man Adv Immunol 16 1973 185 264